As a leader in telemedicine-enabled infectious disease care, antimicrobial stewardship, and infection prevention and control, Infectious Disease Connect is excited to share valuable insights at IDWeek™ 2024. This premier event, gathering over 10,000 attendees, will take place from October 16-19, 2024, in Los Angeles, CA. We look forward to connecting with fellow leaders in infectious diseases.
Speakers and topics include:
Rima Abdel Massih, M.D.
President & Chief Executive Officer
ID Telehealth Cases: Do’s And Don’ts for Different Telecare Modalities
Moderator
ID Physician Compensation Update: It’s About Time (and Value)
Panelist
Quality/Outcome Based Incentives: The Road to Value
Speaker
Matthew Davis, PharmD, BCIDP
Director of Infectious Diseases Pharmacy Services
Implementation and outcomes of a fully remote tele-ID and tele-OPAT program at a regional medical center
Infectious Diseases Pharmacist Curbsides: Questions Infectious Diseases Providers Ask Infectious Diseases Pharmacists
Lead author, poster presenter
Should Paucity Give Us Pause? Revisiting Data Behind Common Practices in Infectious Diseases
SIDP Annual Meeting presenter
Nupur Gupta, DO, MPH
Infectious Diseases Specialist
Lead Author
Seema Mehta Steinke, M.D., M.S.
Infectious Diseases Specialist
Poster Presenter
Observational Comparison of In-Person vs. Remote Care for Bone and Joint Infections
Erin K. McCreary, PharmD, BCPS, BCIDP
Director of Stewardship Innovation, Infectious Disease Connect; Director of Infectious Diseases Improvement and Clinical Research Innovation, UPMC; Clinical Assistant Professor of Medicine, University of Pittsburgh
Best Practices in Antimicrobial Stewardship Programs ($)
Workshop moderator
Beyond the 101: Pondering Perplexing Prescribing Issues
Moderator
Population Pharmacokinetics of Meropenem-Vaborbactam in Acutely Ill Hospitalized Patients with Various Degrees of Renal Dysfunction
Co-Author
Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
Co-Author
Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)
Co-Author
Diana Zhong, M.D., MHS
Infectious Diseases Specialist
Out-BREAK! – an ID Escape Room
Co-creator and organizer
IDWeek™ uniquely unites infectious diseases clinicians, investigators, and infection preventionists to explore current developments in the field of Infectious Diseases (ID). Sponsored by the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists, this annual meeting bridges the fields of real-world ID clinical practice and research.
You might also like…
Infectious Disease Connect and UNM SRMC Release Groundbreaking White Paper on Telemedicine’s Impact on Infectious Disease Care
ID Connect Named “Telehealth Company to Know” by Becker’s Hospital Review
How a Comprehensive Telemedicine Service Model Can Cover an Entire Health Network